Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2023 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
Sreeram Ramagopalan
Sreeram (Ram) Ramagopalan is the Global Head for Real World Evidence for Market Access at Roche. Dr Ramagopalan’s team strategically plans and executes real world research studies to obtain and maintain access for Roche medicines. Dr Ramagopalan holds a PhD in Epidemiology from the University of Oxford, as well as an MSc in Epidemiology from the London School of Hygiene and Tropical Medicine. Prior to Roche, Dr Ramagopalan led European Real World Evidence teams at Bristol Myers Squibb and the life-sciences consultancy Evidera. He is an international expert in real world evidence with over 270 peer reviewed publications.
João Dias
Dr. João Dias is an honors graduate of the University of Helsinki. He received his Licentiate/MSc in biochemistry from the Universities of Porto, Portugal and Wageningen, the Netherlands; and his PhD studies in Immuno-Oncology and Gene Therapy at Helsinki University Central Hospital and Helsinki University, faculty of Medicine. He is currently responsible for international medical affairs and clinical development for the medical devices and diagnostics portfolio at Haemonetics which includes Hemostasis Management, Cell Salvage and Transfusion Management products. Prior to this role, João had a variety of roles of increasing responsibility in the areas of both market access and medical marketing. He has authored several peer-reviewed publications and white papers in the fields of Hemostasis, Patient Blood Management, Immuno-Oncology, Gene Therapy, Hematology, and Molecular Biology. Prior to his tenure at Haemonetics, João worked as a scientist in the development of new products in Cancer Gene Therapy and served as a Life Sciences Consultant working together with multiple global life-science companies.”
Lode Dewulf
Lode Dewulf currently works as board member, consultant, coach and volunteer in the fields of his passions: personal development, patient affairs, medical affairs and business strategy. He sees these part-time roles as a real privilege, after a rich and varied full-time career of over 30 years in the pharmaceutical industry, which he joined after his medical training and practice.
As a physician he worked in general/family medicine settings, as well as in several hospital specialties in both Western and Third World settings. In industry he served and gained experience in several functions, including Medical Affairs, Drug Safety, and Health Economics, always taking the patient’s needs as goal and reference point. He worked in different disease areas, companies, countries and continents, which added to a very diverse experience base. His scope of responsibility within industry grew over the years, and he held several global roles, including as Global Medical Director, Global Head of Compliance and Global Head of Medical Affairs.
In 2012 he was appointed as the industry’s first senior executive officer dedicated to Patient Affairs. In this role he has helped to build bridges and impactful alliances between the willing, which have contributed to deep changes in strategy and culture within companies as well as to several external initiatives with great patient value, such as PFMD, PARADIGM and new FDA Guidance on Pregnancy and Lactation requirements.
He feels most proud of the relations and friendships that he has been able to build over the years. This also includes the mentoring and growing of several talented colleagues into impactful leadership roles, something he continues to do through his teaching and his work as executive coach.
Arron Mungul
Arron joined Bristol-Myers Squibb (BMS) in 2015 in the Global Medical Affairs team, where he was the Market Interface Lead, supporting the implementation of local strategy and launches across oncology. Currently, Arron is part of the Medical Capabilities group, leading an international team responsible for the medical content supporting the execution of local medical affairs plans in Europe and Canada for the entire BMS portfolio.
Prior to BMS, Arron was a Senior Scientific Director in Global Medical Affairs at GSK Oncology and Novartis Oncology, responsible for scientific strategy and communications across several brands. He has also worked in medical communications agencies in London and Switzerland.
Arron received his degree in Biochemistry from Imperial College, London, and his PhD from the Imperial Cancer Research Fund/Cancer Research UK for his work in breast cancer.
